Duke University-ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2024

  1. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

2023

  1. Equity, diversity, and inclusion at the Global Alliance for Genomics and Health

    Cell Genomics, Vol. 3, Núm. 10

2018

  1. Increased indoleamine-2,3-dioxygenase activity is associated with poor clinical outcome in adults hospitalized with influenza in the INSIGHT FLU003Plus study

    Open Forum Infectious Diseases, Vol. 5, Núm. 1

2012

  1. Different effects of unexpected changes in environmental conditions on prepulse inhibition in rats and humans

    Physiology and Behavior, Vol. 106, Núm. 4, pp. 542-547

  2. Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia in HIV/HCV-coinfected patients with All HCV genotypes

    Journal of Infectious Diseases, Vol. 205, Núm. 3, pp. 376-383

2011

  1. Interleukin-28B gene polymorphisms do not influence the susceptibility to HIV-infection or CD4 cell decline

    AIDS, Vol. 25, Núm. 2, pp. 269-271

2010

  1. Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients

    AIDS, Vol. 24, Núm. 8

2003

  1. Virus load and cytolitic responses in human immunodeficiency virus infection: What is cause and what is effect (multiple letters)

    Journal of Infectious Diseases

2001

  1. Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease

    Transplantation, Vol. 72, Núm. 12, pp. 1924-1929